These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16393678)

  • 1. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders.
    Agis H; Krauth MT; Böhm A; Mosberger I; Müllauer L; Simonitsch-Klupp I; Walls AF; Horny HP; Valent P
    Am J Clin Pathol; 2006 Feb; 125(2):273-81. PubMed ID: 16393678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.
    Agis H; Krauth MT; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz LB; Printz D; Böhm A; Fritsch G; Horny HP; Valent P
    J Clin Pathol; 2006 Apr; 59(4):396-402. PubMed ID: 16461568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIP-1α/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
    Baba T; Tanabe Y; Yoshikawa S; Yamanishi Y; Morishita S; Komatsu N; Karasuyama H; Hirao A; Mukaida N
    Blood; 2016 May; 127(21):2607-17. PubMed ID: 27006388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.
    Hidalgo-Lόpez JE; Kanagal-Shamanna R; Quesada AE; Gong Z; Wang W; Hu S; Medeiros LJ; Bassett RL; d'Orcy E; Yin CC; Cortes J; Jabbour EJ; Kantarjian HM; Bueso-Ramos CE
    Cancer; 2018 Oct; 124(19):3849-3855. PubMed ID: 30321462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.
    Kvasnicka HM; Thiele J
    Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph
    Sadovnik I; Ivanov D; Smiljkovic D; Stefanzl G; Degenfeld-Schonburg L; Herndlhofer S; Eisenwort G; Hauswirth AW; Sliwa T; Keil F; Sperr WR; Valent P
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
    Valent P; Agis H; Sperr W; Sillaber C; Horny HP
    Leuk Lymphoma; 2008 Apr; 49(4):635-8. PubMed ID: 18398724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differences and correlations of BCR-ABL transcripts between peripheral blood and bone marrow assays are associated with the molecular responses in the bone marrow for chronic myelogenous leukemia.
    Jiang Q; Zhao XY; Qin YZ; Liu YR; Lai YY; Jiang B; Huang XJ
    Am J Hematol; 2012 Dec; 87(12):1065-9. PubMed ID: 22965919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
    Lewis ID; Haylock DN; Moore S; To LB; Hughes TP
    Leukemia; 1997 Apr; 11(4):581-7. PubMed ID: 9096699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
    Thiele J; Kvasnicka HM
    Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
    Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD
    Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the basophil-specific antibodies 2D7 and BB1 in patients with cutaneous Mastocytosis.
    Idoate MA; Echeveste J; Gil P; Sanz ML; Ferrer M
    J Investig Allergol Clin Immunol; 2013; 23(6):392-7. PubMed ID: 24459815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia.
    Krämer A; Löffler H; Bergmann J; Hochhaus A; Hehlmann R
    Leukemia; 2001 Jan; 15(1):62-8. PubMed ID: 11243401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.